Search This Blog

Thursday, November 12, 2026

Twist F Q4 loss 32 cents per share, narrower than 39-cent analyst consensus

 

Twist Bioscience reports fiscal Q4 2026 revenue of $126.6M, up 28% YoY, beats estimates and forecasts full-year revenue of $550M-$560M

  • Fiscal Q4 loss was 32 cents per share, narrower than the 39-cent analyst consensus, with a $20.6M net loss.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)